About us
Who we are
Governance
Staff
Vacancies
What we do
Members
EuropaBio Members
About Membership
How we work
Healthcare Biotechnology Council
Cell & Gene Therapies
Medicines For Rare Diseases And Children
Regulatory Efficiency
Biosimilars & Public Procurement
Data & Digital
Patient Bio-Forum
Industrial Biotechnology Council
Food, Feed & Nutrition
Circular Bioeconomy
National Associations Council
SME Platform
Biomanufacturing Platform
Activities
25 Years of Innovation
EFIB 2022
European Biotech Week
Events
Newsroom
News & Publications
Newsletter
Library
Become a member
✕
01/02/2023
01/02/2023
Joint Statement: The Data Act is a leap into the unknown
16/01/2023
16/01/2023
SwiftPharma joins EuropaBio: pioneering sustainable, scalable and affordable plant-made therapeutic proteins
19/12/2022
19/12/2022
EuropaBio sat down with new member Association of Biotechnological Companies Bioforum, to find out how they champion biotech in central and eastern Europe
06/07/2022
06/07/2022
Value of Biotech
29/06/2022
29/06/2022
EuropaBio’s Vision for Europe: Innovation, Investment, Excellence
27/06/2022
27/06/2022
Unlocking the Promise of Gene Therapy
20/06/2022
20/06/2022
Seizing opportunities for continued innovation, investment, and excellence in orphan medicines in Europe
25/05/2022
25/05/2022
European Week Against Cancer 2022 – Interview with Santiago Aguirre, Market Lead Europe Oncology, Sanofi
23/05/2022
23/05/2022
Big Changes Start Small
16/05/2022
16/05/2022
EuropaBio Statement on the Evaluation of the Cross-Border Healthcare Directive
25/04/2022
25/04/2022
Opinion: A long journey to care, or why it’s time for an ambitious EU framework for a cross-border healthcare
04/04/2022
04/04/2022
EuropaBio NAC Summit 2022: key recommendations on how National associations can deliver Europe’s innovation, investment and excellence in biotechnology
28/02/2022
28/02/2022
EuropaBio Statement on Rare Disease Day
31/01/2022
31/01/2022
EuropaBio becomes a partner of a new European partnership for health
22/12/2021
22/12/2021
EuropaBio: Revision of the EU general pharmaceuticals legislation for a healthier tomorrow
13/12/2021
13/12/2021
Interview with Ingmar Hoerr, CureVac Founder and holder of the first patents associated with mRNA
EuropaBio sat down with New Member Olon, to find out about their Plans to Expand their Biotechnology Platform.
22/11/2021
22/11/2021
The review of the general pharmaceutical legislation: an opportunity that should not be missed?
26/10/2021
26/10/2021
Healthy Planet, Healthy People: a Pathway for Green Transition in the Biopharmaceutical Ecosystem
19/10/2021
19/10/2021
EuropaBio Patient Bio-Forum: challenges and future potential of European Reference Networks
30/09/2021
30/09/2021
Artificial intelligence: investing in new technologies in healthcare
What if machine learning and artificial intelligence could learn to detect one of the most common forms of blood cancer, through evaluating data based on the gene activity of blood cells?
08/09/2021
08/09/2021
Treatment Without Borders: The EU Case for Equitable Patient Access to Advanced Therapies
02/08/2021
02/08/2021
EuropaBio response to the European Commission Public Consultation on the Regulations for Orphan Medicinal Products and Paediatrics
EuropaBio has responded to the European Commission’s public consultation on the Orphan Medicinal Products (OMPs) and Paediatrics Regulations.
29/07/2021
29/07/2021
EuropaBio response to the Public Consultation ‘Digital Health Data and Services – The European Health Data Space’
Load more
Become a member